Characteristics of serum hyaluronate concentrations in patients with alcoholic liver disease

Alcoholism: Clinical and Experimental Research

Volumn 21, Issue 9, 1997, Pages 1716-1721

  Tsutsumi, Mikihiro ^a   Urashima, Sachio ^a   Takase, Shujiro ^a   Ueshima, Yasuhiro ^a   Tsuchishima, Mutsumi ^a   Shimanaka, Koshi ^a   Kawahara, Hiromu ^a  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

Author keywords

Alcoholic Liver Disease; Laminin; Serum Hyaluronate Concentration; Sinusoidal Capillarization; Type IV Collagen

Indexed keywords

ALCOHOL; ALPHA INTERFERON; COLLAGEN TYPE 4; HYALURONIC ACID; LAMININ;

ALCOHOL LIVER CIRRHOSIS; ALCOHOL LIVER DISEASE; ALCOHOLISM; ARTICLE; CHRONIC HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; HEPATITIS C; HUMAN; LIVER FIBROSIS; LIVER SINUSOID; PRIORITY JOURNAL;

HEPATITIS C VIRUS; PHASEOLUS (ANGIOSPERM);

EID: 0031461211     PISSN: 01456008     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1530-0277.1997.tb04513.x     Document Type: Article

References (27)

1. Popper H, Thung SN, Gerber MA: Pathology of alcoholic liver diseases. Semin Liver Dis 1:203-216, 1981
2. Takada A, Nei J, Matsuda Y, Kanayama R: Clinicopathological study of alcoholic fibrosis. Am J Gastroenterol 77:660-666, 1982
3. Horn T, Junge J, Christoffersen P: Early alcoholic liver injury: Changes of the Disse space in acinar zone 3. Liver 5:301-310, 1985
4. Urashima S, Tsutsumi M, Nakase K, Wang J-S, Takada A: Studies on capillarization of the hepatic sinusoids in alcoholic liver disease. Alcohol Alcohol 28:77-84, 1993
5. Le Bail BL, Bioulac-Sage P, Senita R, Quinton A, Saric J, Balabaud C: Fine structure of hepatic sinusoids and sinusoidal cells in disease. J Electron Microsc Tech 14:257-282, 1990
6. Tsutsumi M, Urashima S, Matsuda Y, Takase S, Takada A: Changes in type IV collagen content in livers of patients with alcoholic liver disease. Hepatology 17:820-827, 1993
7. Tsutsumi M, Urashima S, Nakase K, Takase S, Takada A: Changes in laminin content in livers of patients with alcoholic liver disease. Liver 15:324-331, 1995
8. Engstrom-Laurent A, Loof L, Nyberg A, Schröder T: Increased serum levels of hyaluronate in liver disease. Hepatology 5:638-642, 1985
9. Frebourg T, Delpech B, Bercoff E, Senant J, Bertrand P, Deugnier Y, Bourreille J: Serum hyaluronate in liver diseases: Study by enzymoimmunological assay. Hepatology 6:392-395, 1986
10. Bentsen KD, Horn T, Risteli L, Engstrom-Laurent A, Petersen KH, Lorenzen IB, the Copenhagen Study Group on Fibrotic Diseases: Serum aminoterminal type III procollagen peptide and 7S domain of type IV collagen in patients with alcohol abuse. Liver 7:339-346, 1987
11. Nyberg A, Engstrom-Laurent A, Loof L: Serum hyaluronate in primary biliary cirrhosis: A biochemical marker for progressive liver damage. Hepatology 8:141-146, 1988
12. Babbs C, Haboubi NY, Mellor JM, Smith A, Rowan BP, Warnes TV: Endothelial cell transformation in primary biliary cirrhosis: A morphological and biochemical study. Hepatology 11:723-729, 1990
13. Gibson PR, Fraser JRE, Brown TJ, Finch CF, Jones PA, Colman JC, Dudley FJ: Hemodynamic and liver function predictors of serum hyaluronate in alcoholic liver disease. Hepatology 15:1054-1059, 1992
14. Ueno T, Inuzuka S, Torimura T, Tamaki S, Koh H, Kin M, Minetoma T, Kimura Y, Ohira H, Sata M, Yoshida H, Tanikawa K: Serum hyaluronate reflects hepatic sinusoidal capillarization. Gastroenterology 105:475-481, 1993
15. Takada A, Tsutsumi M: Diagnostic criteria for alcoholic liver disease. Int Hepatol Commun 3:63-69, 1995
16. Mimms L, Vallari D, Ducharme L, Holland P, Kuramoto IK, Zeldis J: Specificity of anti-HCV ELISA assessed by reactivity to three immunodominant HCV regions. Lancet 336:1590-1591, 1990
17. Okamoto H, Okada S, Sugiyama Y, Tanaka T, Sugai Y, Akahane Y, Machida A, Mishiro S, Yoshizawa H, Miyakawa Y, Mayumi M: Dé tection of hepatitis C virus RNA by a two-stage polymerase chain reaction with two pairs of primers deduced from the 5'-ndncoding region. Jpn J Exp Med 60:215-222, 1990
18. Tsutsumi M, Wang J-S, Takada A: Microheterogeneity of serum glycoproteins in alcoholics: Is desialo-transferrin the marker of chronic alcohol drinking or alcoholic liver injury? Alcohol Clin Exp Res 18:392397, 1994
19. Chichibu K, Matsuura T, Shichijo S, Yokoyama M: Assay of serum hyaluronic acid in clinical application. Clin Chim Acta 181:317-324, 1989
20. Gressner AM, Schafer S: Comparison of sulfated glycoaminoglycan and hyaluronate synthesis and secretion in culture hepatocytes, fat storing cell, and Kupffer cells. J Clin Biochem 27:141-149, 1989
21. Eriksson S, Fraser JRE, Laurent TC, Pertoft H, Smedsrod B: Endothelial cells are a site of uptake and degradation of hyaluronic acid in the liver. Exp Cell Res 144:223-228, 1983
22. Smedsrod B, Pertoft H, Eriksson S, Fraser JRE, Laurent TC: Studies in vitro on the uptake and degradation of sodium hyaluronate in rat liver endothelial cells. Biochem J 223:617-626, 1984
23. Fraser JRE, Alcorn D, Laurent TC, Robinson AD, Ryan GB: Uptake of circulating hyaluronic acid by the rat liver: Cellular localization in situ. Cell Tissue Res 242:505-510, 1985
24. McGary CT, Raja RH, Weigel PH: Endocytosis of hyaluronic acid by rat liver endothelial cells: Evidence for receptor recycling. Biochem J 257:875-884, 1989
25. Guechot J, Loria A, Serafty L, Giral P, Giboudeau J, Poupon R: Serum hyaluronan as a marker of liver fibrosis in chronic viral hepatitis C: Effect of a-interferon therapy. J Hepatol 22:22-26, 1995
26. Urashima S, Tsutsumi M, Takada A: Studies on hepatic fibrosis in alcoholic liver injury. I. Immunohistochemical study. J Kanazawa Med Univ 17:381-389, 1992 (in Japanese)
27. Urashima S, Tsutsumi M, Takada A: Studies on hepatic fibrosis in alcoholic liver injury. II. Immunoelectron microscopic study. J Kanazawa Med Univ 17:390-397, 1992 (in Japanese). t